LabCompass

Andrew C. Huntsman

Pharmacology, Toxicology and Pharmaceutics · The Ohio State University

Mid career · publishing since 2013Rising activity

Publications

16

Citations

178

Est. group size

~1

Recurring co-author estimate

Active years

12

Publishing since 2013

Research summary
AI-generated

Andrew C. Huntsman's research focuses on natural products derived from fungi, particularly a class of compounds called verticillins, which show potential as anti-cancer (chemotherapeutic) agents. Work includes both studying these compounds as they occur in nature and chemically modifying them to create new derivatives with potentially improved properties. This research sits within pharmacology and medicinal chemistry, exploring how natural fungal molecules might be developed into therapeutic drugs.

Natural product drug discoveryFungal secondary metabolites (verticillins)Medicinal chemistry and semisynthesisAnti-cancer compound developmentPhytochemistry and bioactive compounds

Publication output has been low and irregular over the past decade, with a notable spike in 2023 followed by a return to a slower pace, averaging about 1-2 papers per year in the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.4/year recently
2017: 1 publication172018: 3 publications182019: 1 publication192020: 1 publication202021: 1 publication212022: 1 publication222023: 5 publications5232024: 1 publication242526
Publishes in
  • Cell Death and Disease×1
  • Bioorganic & Medicinal Chemistry×1
  • European Journal of Medicinal Chemistry×1
  • Molecular Cancer Therapeutics×1
  • ACS Medicinal Chemistry Letters×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile